Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEGYN vs Gynomax XL for Vaginal Infections
NCT06056947Phase 3Completed
- Sponsor
- Ege University
- Start
- Jul 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fenticonazole, tinidazole and lidocaine in bacterial vaginosis (BV), candidal vulvovaginitis, trichomonal vaginitis and 1 more (3 arms), sponsored by Ege University. Primary endpoint: Percentage of patients who had complete response to treatment according to clinical findings at 13 days. Started Jul 2020; status: completed.
02
Drugs
fenticonazoletinidazolelidocaine
03
Conditions
bacterial vaginosis (BV)candidal vulvovaginitistrichomonal vaginitismixed vaginitis
Beyond the preview
Go deeper on NCT06056947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06056947.